Literature DB >> 12546586

Side-branched modular endograft system for thoracoabdominal aortic aneurysm repair.

Jacques Bleyn1, François Schol, Inga Vanhandenhove, Peter Vercaeren.   

Abstract

PURPOSE: To describe a side-branched modular endograft system that provides adequate visceral artery perfusion with perfect seal during thoracoabdominal aortic aneurysm (TAAA) repair. CASE REPORT: A 76-year-old man with a 57-mm TAAA involving the celiac artery was treated with a customized Talent endograft consisting of a 46-mm x 18-cm stented main body and a 6-mm x 30-mm nonstented Dacron side branch. The graft was delivered through a surgical exposure of the left common femoral artery. A 6-mm x 10-cm Hemobahn stent-graft was introduced in the 30-mm side branch from the aorta to the celiac trunk through a long 8-F sheath via the left brachial artery. The patient recovered uneventfully except for a mild reactive inflammatory syndrome. Postoperative computed tomography demonstrated total exclusion of the TAAA sac and good antegrade perfusion of the celiac and superior mesenteric arteries, which has been maintained at the 6-month follow-up.
CONCLUSIONS: Endovascular treatment of TAAA is feasible with further technical refinements of available technology.

Entities:  

Mesh:

Year:  2002        PMID: 12546586     DOI: 10.1177/152660280200900618

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  2 in total

1.  Thoracic stent graft with distal fenestration for the superior mesenteric artery for treatment of thoracic aortic aneurysm.

Authors:  Ryota Fukunaga; Takuya Matsumoto; Yukihiko Aoyagi; Daisuke Matsuda; Shinichi Tanaka; Jun Okadome; Koichi Morisaki; Yoshihiko Maehara
Journal:  Ann Vasc Dis       Date:  2014-03-31

Review 2.  Branched endovascular stent-graft for suprarenal aortic aneurysm: the future of aortic stent-grafting?

Authors:  Leonard W Tse; Oren K Steinmetz; Cherrie Z Abraham; David A Valenti; Kent S Mackenzie; Daniel I Obrand; Timothy A Chuter
Journal:  Can J Surg       Date:  2004-08       Impact factor: 2.089

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.